论文标题
贝叶斯的方法用于分析早期肿瘤学篮试验,并在癌症类型上借用信息
Bayesian Methods for the Analysis of Early-Phase Oncology Basket Trials with Information Borrowing across Cancer Types
论文作者
论文摘要
肿瘤学的研究已将重点从特定器官中肿瘤的组织学特性转变为可能由多种癌症类型共享的特定基因组畸变。这激发了篮子试验,该试验评估了治疗对多种具有常见畸变的癌症类型的功效。尽管鉴于共同的畸变,但均质治疗效应的假设似乎是合理的,但实际上,治疗效果可能因癌症类型而有所不同,并且可能只有癌症类型的亚组对治疗做出反应。已经提出了各种方法来通过借用癌症类型的信息来提高试验能力,但是,这往往会膨胀I型错误率。在本文中,我们回顾了一些代表性的贝叶斯信息借贷方法,用于分析早期篮子试验。然后,我们提出了一种具有相关先验(CBHM)的新方法,称为贝叶斯分层模型,该模型根据样本相似性,在癌症类型上进行更灵活的借贷。我们进行了仿真研究,将CBHM与独立分析和三种信息借用方法进行比较:常规的贝叶斯分层模型,EXNEX方法和LIU的两阶段方法。仿真结果表明,如果很大一部分癌症类型真正对治疗做出反应,则所有信息借贷方法都大大提高了独立分析的能力。我们提出的CBHM方法比现有信息借贷方法具有优势,其功率与Exnex或Liu的方法相似,但是提供了更好地控制I型错误率的潜力。
Research in oncology has changed the focus from histological properties of tumors in a specific organ to a specific genomic aberration potentially shared by multiple cancer types. This motivates the basket trial, which assesses the efficacy of treatment simultaneously on multiple cancer types that have a common aberration. Although the assumption of homogeneous treatment effects seems reasonable given the shared aberration, in reality, the treatment effect may vary by cancer type, and potentially only a subgroup of the cancer types respond to the treatment. Various approaches have been proposed to increase the trial power by borrowing information across cancer types, which, however, tend to inflate the type I error rate. In this paper, we review some representative Bayesian information borrowing methods for the analysis of early-phase basket trials. We then propose a novel method called the Bayesian hierarchical model with a correlated prior (CBHM), which conducts more flexible borrowing across cancer types according to sample similarity. We did simulation studies to compare CBHM with independent analysis and three information borrowing approaches: the conventional Bayesian hierarchical model, the EXNEX approach and Liu's two-stage approach. Simulation results show that all information borrowing approaches substantially improve the power of independent analysis if a large proportion of the cancer types truly respond to the treatment. Our proposed CBHM approach shows an advantage over the existing information borrowing approaches, with a power similar to that of EXNEX or Liu's approach, but the potential to provide substantially better control of type I error rate.